Join DDW for this free event, ‘Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics’, which is supported by Revvity. It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron… Read More
Join DDW for this free event, ‘Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics’, which is supported by Revvity. It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron… Read More
Join DDW for this free event, ‘Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics’, which is supported by Revvity. It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron… Read More
Join DDW for this free event, ‘Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics’, which is supported by Revvity. It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will presented by Ron Morena,… Read More
Successful development of advanced biotherapeutics relies on extensive characterisation and tight quality control. Characterising binding properties of complex biomolecules is a critical step. Biophysical data combined with functional assays are needed to predict efficacy and potency, optimise drug delivery, assess critical quality attributes, and improve biologics drug design. Traditional approaches have… Read More
Dr Sofia Ferreira, Director of Applications at Refeyn, discusses how various technologies can address the main challenges in membrane protein characterisation, describing how novel technologies, such as mass photometry, can streamline and support analytical processes. Dissecting the structure of membrane proteins Membrane proteins play a crucial role… Read More
Feeling isomer FOMO? Download this new whitepaper from MOBILion Systems ‘High-Throughput Monitoring of Biotherapeutic Critical Quality Attributes with High-Resolution Ion Mobility-Mass Spectrometry (HRIM-MS)’. MOBILion Systems is pioneering the evolution of separation science. High-resolution ion mobility (HRIM) on the MOBIE platform offers deeper, more accurate, and efficient characterisation of… Read More
MOBILion Systems is pioneering the evolution of separation science. High-resolution ion mobility (HRIM) on the MOBIE platform offers deeper, more accurate, and efficient characterisation of complex molecules than traditional methods. Download the whitepaper “High-Throughput Monitoring of Biotherapeutic Critical Quality Attributes with High-Resolution Ion Mobility-Mass Spectrometry (HRIM-MS)” to learn more about:… Read More
Professor Michael Butler, head of the National Institute for Bioprocessing Research and Training (NIBRT) Cell Technology Group (CTG), explains that the characterisation and analysis of glycans is important for the biopharma sector as it can help in the development of therapeutic agents such as monoclonal antibodies and other… Read More
The ability to monitor biologic candidates’ propensity towards self-association is critical for predicting whether a therapeutic is likely to aggregate or become difficult to administer due to viscosity. In this app note, read how Merck KGaA uses light scattering measurements to predict how formulations will behave at clinically relevant… Read More
Creoptix, a Switzerland-based company focused on next-generation bioanalytical instruments, has launched waveRAPID (Repeated Analyte Pulses of Increasing Duration), a novel, label-free kinetic measurement method that is said to be faster than traditional kinetics. The company developed the Creoptix WAVEsystem to enable molecular interactions to be studied in real time, aimimng… Read More
